Introduction {#Sec1}
============

Many molecules, such as several peptides and proteins, exert their effects at the cell membrane level, which makes necessary investigating their interactions with lipids to study their mechanisms of action and side effects (Reddy et al. [@CR18]; Dawson and Liu [@CR5]; Hancock and Chapple [@CR9]). Liposomes or lipid vesicles are useful as a membrane model system because they mimic the cell membrane properties in a wide range of interactions. The molecular in-depth location and orientation in lipid bilayers of a given molecule can be studied using liposomes and other lipid models (Lopes and Castanho [@CR13]; Troeira Henriques et al. [@CR23]; Castanho et al. [@CR4]; Castanho and Fernandes [@CR3]). Determination of molecular lipid/water partition constants (*K*~*p*~) is frequently used to quantify the extension of the interaction (Santos et al. [@CR22]; Ribeiro et al. [@CR19]). The determination of this parameter has been achieved by using different methodologies, such as UV-Vis absorption spectrophotometry, fluorescence spectroscopy and ζ-potential (zeta-potential) measurements. These three techniques are among the most used to calculate *K*~*p*~ without physical separation of the "lipid phase" from "aqueous phase", as happens in chromatographic techniques (Santos et al. [@CR22]; Matos et al. [@CR15]; Ribeiro et al. [@CR19]). Another advantage of these techniques is the use of optical signals, which are noninvasive to the system under study. However, both UV-Vis spectrophotometry and fluorescence spectroscopy require molecules that have chromophores or fluorophores in their structures (Santos et al. [@CR22]). At variance, application of ζ-potential-based methodologies only require charged molecules in the system in order to measure surface charge alterations when molecules interact with liposomes (Kaszuba et al. [@CR10]).

Polyelectrolyte particles in a suspension attract ions to their surface. These ions form a layer covering the particle surface, commonly named the Stern layer (Fig. [1](#Fig1){ref-type="fig"}). Another layer outside the Stern layer is also formed, where ions diffuse more freely. Within the diffuse layer there is a notional boundary inside which the particle forms a stable entity. When a particle moves, in the presence of an electrical field, the ions within this boundary move with it. In the diffuse boundary, the ions do not move concomitantly to the scattering particle. The electric potential that exists at this boundary is called the ζ-potential (Domingues et al. [@CR7]; Kaszuba et al. [@CR10]). This potential determines the electrophoretic mobility of the particles in solution on the progression towards the electrode of opposite charge in the presence of an electric field. Viscous forces oppose to the movement of the particles until equilibrium, when a constant velocity is reached. The electrophoretic mobility can be calculated through the analysis of electrophoresis performed with different experimental conditions. Alternatively, it can be determined by laser Doppler velocimetry using dynamic light scattering-based ζ-potential measurement devices, in which particle velocity is related to frequency, measured by intensity fluctuation of the scattered light. However, the sensitivity of the Doppler effect to the low mobility of larger particles is very low, making it difficult for the electrophoretic mobility to be calculated. Some newer devices can use a different method for calculating electrophoretic mobility. This method was developed in the early 1990s by Miller et al. ([@CR17]) and is based on phase shift analysis, where differences in phases between an unshifted reference beam and the sample-scattered beam are analyzed with higher sensitivity. This phase shift is related to the position of the particle. Hence, the mean phase change with time yields the electrophoretic motion (Miller et al. [@CR17]; Tscharnuter [@CR24]). Using Henry's relation (Delgado et al. [@CR6]), it is possible to calculate the ζ-potential of the particle:Fig. 1Schematic representation of the double layer that surrounds a particle in aqueous medium. The potential that exists at the slipping plane is known as the ζ-potential. Taken from (Malvern [@CR14])$$\documentclass[12pt]{minimal}
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In this equation, *z* is the ζ-potential, *U*~E~ the electrophoretic mobility and *f*(ka) the Henry's function (Delgado et al. [@CR6]; Kirby and Hasselbrink [@CR11]). Thus, the ζ-potential enables the assessment of the membrane potential, which in turn depends on the adsorption or insertion of charged molecules in lipid bilayers. This allows quantifying the extent of the binding between charged molecules and lipid membranes, from which the *K*~*p*~ can be obtained.

In this work we derived and tested a mathematical model to determine the *K*~*p*~ from ζ-potential data. We compared the values obtained with those obtained by fluorescence spectroscopy, which is a regular technique used to quantify peptide/lipid interactions in selected biomembrane model systems (Santos et al. [@CR22]). Two antimicrobial peptides (AMP) were studied by this new method: BP100 (KKLFKKILKYL-NH2), a short cationic cecropin A-melittin hybrid with activity against several plant pathogenic gram-negative bacteria (Alves et al. [@CR1]; Ferre et al. [@CR8]), and pepR (LKRWGTIKKSKAINVLRGFRKEIGRMLNILNRRRR), a peptide derived from the putative RNA-binding domain of the dengue virus capsid protein (Alves et al. [@CR1]). The results obtained by this new methodology show that ζ-potential is a powerful technique to quantify protein/lipid interactions of a wide variety of charged molecules, overcoming some of the limitations inherent to other techniques.

Materials and methods {#Sec2}
=====================

Materials {#Sec3}
---------

2-(4-(2-Hydroxyethil)-1-piperazinyl)-ethanosulfonic acid (HEPES), sodium chloride, chloroform, dimethlyl sulfoxide (DMSO), ethanol (Spectroscopic grade) and [l]{.smallcaps}-tryptophan from Merck (Darmstadt, Germany) were used. Phospholipids 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-[l]{.smallcaps}-serine (POPS) and 1-palmitoyl-2-oleoyl-sn-glycero-3-(phosphor-rac-(1-glycerol)) (POPG) were from Avanti Polar Lipids (Alabaster, AL). Unless otherwise stated, all solutions were prepared in HEPES buffer pH 7.4 (10 mM HEPES, 150 mM of NaCl).

Preparation of lipid vesicles {#Sec4}
-----------------------------

Large unilamellar vesicles (LUV) were prepared by extrusion of multilamellar vesicles (MLV) using a mini-extruders from Avanti Polar Lipids (Alabaster, AL) and used as biological membrane models (Santos and Castanho [@CR21]; Mayer et al. [@CR16]). MLVs were obtained from the hydration with pH 7.4 HEPES buffer of vacuum-dried phospholipid films that were previously dissolved in chloroform (Mayer et al. [@CR16]). The extrusion protocol was carried out using 1001RN syringes (Hamilton, Reno, NV) with 13-mm-diameter membrane filters (400-nm pore) and 100-nm-pore polycarbonate 10-mm-diameter membranes from Nucleopore-Wathman (Kent, UK), leading to the production of 100-nm-diameter vesicles.

Determination of the partition constant by fluorescence spectroscopy {#Sec5}
--------------------------------------------------------------------

The formalism for the determination of the partition constant by spectroscopic methods has been described elsewhere (Santos et al. [@CR22]; Ribeiro et al. [@CR19]; Castanho and Fernandes [@CR2]). Briefly, the partition constant can be formulated by:$$\documentclass[12pt]{minimal}
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In Eq. [2](#Equ2){ref-type=""}, *K*~*P*~ represents the partition constant, *n*~*s*,*i*~ and \[*P*\]~*i*~ are respectively the moles of solute and the peptide concentration in each environment *i* (*i* = *W*, water; *i* = *L*, lipid). From Eq. [2](#Equ2){ref-type=""} the fraction of membrane-bound (*X*~*L*~) solute can be related to *K*~*p*~ (Santos et al. [@CR22]):$$\documentclass[12pt]{minimal}
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*X*~*L*~ represents the fraction of peptide that is bound to the lipid, \[*L*\] the phospholipid concentration (considering that the volume is only given by the aqueous volume), and γ~*L*~ is the molar volume of the lipid.

Fluorescence intensity (*I*~*f*~) can be used to study the interaction of fluorophore-bearing molecules, such as tryptophan-containing peptides, with lipid bilayers, as long as the fluorophore is sensitive to changes in its micro-environment, namely, changes in polarity. It is expected that, when in contact with a lipid bilayer, there will be an increase in the tryptophan fluorescence quantum yield, for instance. The variation of the fluorescence intensity with \[*L*\] is a linear combination of the contribution of the molecules in the aqueous or on the lipid phase. The value of *K*~*p*~ is given by (Santos et al. [@CR22]):$$\documentclass[12pt]{minimal}
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Fluorescence measurements were performed on a FS920 fluorescence spectrophotometer FL920 (Edinburgh Instruments, Livingston, UK), using 0.5-cm quartz cells (Hellma, Jena, Germany). The concentration of the fluorophore was used so that the solution had 0.1 of maximum absorbance at the excitation wavelength, optimizing the signal/noise ratio and minimizing inner filter effects. All emission spectra were obtained in the 300--450-nm range, with an excitation wavelength of 280 nm.

The partition experiments using steady-state fluorescence spectroscopy were carried out by titrating a solution of pepR (36 μM) or BP100 (1.5 or 10 μM) with a 15-mM (pepR) or 3.5-mM (BP100) stock suspension of LUV. All the measurements were carried out at room temperature. The system was incubated after each lipid addition for 10 min before fluorescence measurement. By a non-linear fitting of the observable *I*~f~ versus \[*L*\] data, one can obtain the values for the partition constant, *K*~*p*~. Spectra corrections were applied as described elsewhere (Ladokhin et al. [@CR12]) before data analysis.

Determination of the partition constant by zeta-potential {#Sec6}
---------------------------------------------------------

Here we present a mathematical formalism to determine partition constants of polyelectrolytes, such as charged peptides (a characteristic shared by almost all AMP), to lipid vesicles by ζ-potential measurements. The basic assumption of this method is that the particle under study can be electrophoretically displaced, which is a consequence of its global net charge. This method relies on electrostatic interactions, which have an important role in partition phenomena. ζ-Potential is known to be dependent on the binding of a solute to lipid vesicles (LUV) when the net charge is affected (Domingues et al. [@CR7]). Lipid vesicles are also good scatterers; therefore, ζ-potential measurements are an appropriate approach to quantify partition constants. Titrations of lipid vesicles with peptide are performed in order to determine the partition constant from ζ-potential measurements. When a lipid vesicle with a negative ζ-potential interacts with a positively charged peptide, for instance, the ζ-potential value increases, progressively approaching a negative, neutral or positive threshold.

To extract the *K*~*P*~ value by this methodology, it is necessary to know in advance the net charge of the peptide and the proportion and effective charge of the ionic phospholipids in the vesicles. When a positive peptide interacts with negatively charged membrane, for instance, there is a reduction in the magnitude of the surface charge of the membrane. This reduction is proportional to the fraction of charged lipids that are neutralized, given by:$$\documentclass[12pt]{minimal}
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*X*~*L*~ represents the molar fraction of peptide that is in contact with the membrane and is described by Eq. [3](#Equ3){ref-type=""}. \[*L*\] and \[*P*\] are respectively the lipid and peptide concentration, and *f*~PL~ is the fraction of anionic phospholipids in the lipid mixture. Considering that a phospholipid can have more than a single charge, Eq. [7](#Equ7){ref-type=""} can be rearranged to:$$\documentclass[12pt]{minimal}
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                \begin{document}$$ {\frac{{\zeta_{\text{final}} }}{{\zeta_{0} }}} = 1 + {\frac{{X_{L} z_{\text{Peptide}} }}{{f_{PL} \left[ L \right]z_{\text{Lipid}} }}} \cdot \left[ P \right] $$\end{document}$$where *z*~lipid~ is the absolute charge of the lipid and ζ~final~ is the ζ-potential value for each titration with peptide. Plotting ζ~final~/ζ~0~ versus \[*P*\], a linear variation is expected, and it is possible to determine the value of *K*~*P*~ from the slope using Eqs. [8](#Equ8){ref-type=""} and [3](#Equ3){ref-type=""}.

Zeta-potential measurements were performed in a Malvern Ζetasizer Nano ZS apparatus (Malvern, UK) with a backscattering detection at a constant 173° scattering angle, equipped with a He--Ne laser (λ = 632.8 nm), at 25°C. Ζetasizer folded capillary cells DTS 1060 (Malvern, UK) were used in the ζ-potential experiments.

Aliquots of constant 200 μM of LUV were prepared to a final sample volume of 1 ml into a sterile Eppendorf tube and then filtered into the ζ-potential cuvette. Filtered pH 7.4 HEPES buffer was used in all the samples.

For each sample the instrument performed 20 scans (70 runs each), with an initial equilibration time of 15 min, at 25°C and a constant voltage of 40 mV. Values of the viscosity and refractive index were set at 0.8872 cP and 1.330, respectively. Data analysis was processed using the instrumental Malvern's DTS software to obtain the mean ζ-potential value. All experiments were performed in triplicate. Equation [8](#Equ8){ref-type=""} was used to determine the *K*~*p*~ value.

Results and discussion {#Sec7}
======================

We developed a new mathematical formalism to determine *K*~*p*~ from ζ-potential data. To validate this method, the *K*~*p*~ values obtained for two different membrane-active peptides, pepR and BP100, were compared with those calculated from fluorescence spectroscopy-based methodologies (Santos et al. [@CR22]). Figures [2](#Fig2){ref-type="fig"}a, b and [3](#Fig3){ref-type="fig"} show the results obtained for pepR by ζ-potential and fluorescence techniques, respectively. *K*~*p*~ was also obtained for BP100 in POPC:POPG 3:1 lipidic mixtures (Fig. [2](#Fig2){ref-type="fig"}c). The *K*~*p*~ values are summarized in Table [1](#Tab1){ref-type="table"}.Fig. 2Determination of the partition constant by ζ-potential measurements. **a** ζ-Potential measurements of different lipid mixtures in the presence of pepR. *Filled circles* POPC, *empty circles* POPC:POPG 4:1 and *filled triangles* POPC:POPG 3:2. All measurements were performed with a 200 μM LUV suspension with increasing concentrations of pepR. **b** Normalized ζ-potential dependence on the concentration of pepR. The lines represent the best fit of Eq. [8](#Equ8){ref-type=""} to the data. *Empty circles* and *dashed line* POPC:POPG 4:1; *triangles* and *solidline* POPC:POPG 3:2. *Error bars* represent the standard deviation from three independent experiments. **c** Normalized ζ-potential dependence on the concentration of BP100 with a 250-μM POPC:POPG 2:1 LUV solution. The *line* represents the best fit of Eq. [8](#Equ8){ref-type=""} to the data. Raw data of **c** from (Ferre et al. [@CR8])Fig. 3Determination of the partition constant by fluorescence spectroscopy. Partition curves of a 36-μM solution of pepR titrated with different lipid mixtures (LUV). The partition constants were obtained by the non-linear fitting of Eq. [4](#Equ4){ref-type=""} to the data. The *solid lines* represent the non-linear fitting and the *dashed lines* the 95% confidence intervals. *Filled circles* POPC LUVs,*empty circles* POPC:POPG 4:1 and *filled triangles* POPC:POPG 3:2Table 1Values of the partition constants of BP100 and pepR to liposomes with different lipid compositions, at pH 7.4, obtained by ζ-potential and fluorescence spectroscopy measurements. (*K*~*p*~ ± standard deviation)PeptideLipid mixture*K*~*p*~/10^3^Fluorescence spectroscopyζ-PotentialBP100^a^*POPC:POPG 1:2*50.7 ± 9.3056.7 ± 0.70pepR*POPC:POPG 4:1*0.44 ± 0.081.70 ± 0.06*POPC:POPG 3:2*4.50 ± 1.065.50 ± 1.30^a^ζ-Potential data (Ferre et al. [@CR8])

In the ζ-potential experiments, LUV suspensions were titrated with peptide solutions in HEPES buffer. As expected, the interaction of the positively charged peptides with negatively charged LUV causes membrane surface charge to change. Increasingly, positive ζ-potential values are detected and, at higher peptide concentrations, a neutralization of the charge is observed (Fig. [2](#Fig2){ref-type="fig"}a). The increase of the ζ-potential reflects the interaction of the peptides with the lipid bilayers, which progressively neutralizes the net negative charge of the phospholipid polar head group. Significant ζ-potential changes are not observed when using lipid vesicles with neutral global net charge. When POPC vesicles were titrated with pepR no changes in ζ-potential values were observed, being indicative of a weak or even no interaction of the peptide with zwitterionic lipids. These results show that the interaction of pepR with lipid membranes is driven by electrostatic interactions. The ζ-potential values obtained for each peptide were normalized to the initial ζ-potential value of the LUV suspension in the absence of the peptide (ζ~0~). We then applied Eq. [8](#Equ8){ref-type=""} to the obtained results to determine the *K*~*p*~ value of each interaction (see Fig. [2](#Fig2){ref-type="fig"}b and Table [1](#Tab1){ref-type="table"}). The net charges considered were −1, +12 and +6 for the anionic phospholipids, pepR and BP100, respectively.

When fluorescence spectroscopy was applied to calculate *K*~*p*~, a peptide solution was titrated with a LUV suspension. In Fig. [3](#Fig3){ref-type="fig"} an increase in the tryptophan fluorescence intensity is observed due to the increasing number of molecules coming in contact with the nonpolar environment. The quantification of these interactions was done by a non-linear fitting of the obtained results with Eq. [4](#Equ4){ref-type=""} (Table [1](#Tab1){ref-type="table"}).

Both methods retrieved comparable *K*~*p*~ values. ζ-Potential measurements prove to be a reliable method for studying peptide/lipid interactions and for *K*~*p*~ determination. Yet when studying the partition of pepR to 20% charged vesicles the value of *K*~*P*~ from ζ-potential does not totally match. This may be related to pepR being quite long and cationic, and the fraction of anionic phospholipids fairly low, which may result in other factors superimposing to simple electrostatic interactions (White et al. [@CR26]; White and Wimley [@CR25]).

ζ-Potential is a powerful approach when studying charged molecules that are also good scatters. The major drawback of this methodology is the necessity of charged particles. Equation [8](#Equ8){ref-type=""} shows that if both lipid and peptide have no charge, the equation is not valid anymore to calculate the *K*~*p*~. Another assumption that we have to consider when applying this model is that each charge of peptide is responsible for the neutralization of one charge of the lipid. Therefore, a stoichiometry of 1:1 peptide charge:lipid charge is assumed in the model.

When applying the fluorescence spectroscopy-based model, the major requirement is to have a fluorescent reporter in the membrane-active molecule. Many peptides have fluorescent amino acid residues in their sequence, namely tryptophan, tyrosine or phenylalanine (very low signal), and work as reporters of the surrounding environment (Santos and Castanho [@CR20]). However, there are some cases where no reporter is available in the native molecule. To circumvent this problem, molecule labeling with a fluorescent probe is very common. However, peptide labeling may change the biophysical and biological properties of the native molecule and modify their interaction with lipid membranes. With this novel approach of determining *K*~*p*~ by ζ-potential, it is possible to quantify the partition of molecules with no intrinsic fluorescent reporter, as long as they are charged, which is an almost universal condition in some areas of study, such as antimicrobial peptides.
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